Janette Sung

Janette Sung possesses extensive experience in the fields of drug metabolism and pharmacokinetics, having held various scientific roles at renowned organizations such as Gilead Sciences, where responsibilities included Senior Scientist and Research Scientist positions in DMPK Biologics from 2021 to 2025. Prior experience includes roles at Encoded Therapeutics Inc. as Scientist II in Analytical Development, CytomX Therapeutics as Scientist I in Bioanalytics related to Toxicology & Pharmacology, and a foundational position as Associate Scientist at Bristol-Myers Squibb. Janette Sung holds a Master's degree in Environmental Engineering Technology/Environmental Technology from Oklahoma State University and a Master's degree in Biology from the University of Central Oklahoma.